(주)엔테로바이옴(Enterobiome inc.)

Pharmaceutical Manufacturing • Goyang-si, Korea, Republic of • 11-20 Employees

Company overview

Headquarters	Goyang-si, Korea, Republic of
Phone number	+82319687456
Website	enterobiome.com
NAICS	3254
Keywords	Microbiome, Akkermansia, Faecalibacterium, Health Supplyment
Founded	2018
Employees	11-20
Socials

Key Contacts at (주)엔테로바이옴(Enterobiome inc.)

Lukas Lee

Global Business Development Director

Seo Jay

Chief Executive Officer

재구 서

Ceo

(주)엔테로바이옴(Enterobiome inc.) Email Formats

(주)엔테로바이옴(Enterobiome inc.) uses 1 email format. The most common is {first name} (e.g., john@enterobiome.com), used 100% of the time.

Format	Example	Percentage
{first name}	john@enterobiome.com	100%

About (주)엔테로바이옴(Enterobiome inc.)

Enterobiome Inc. is developing microbiome treatments and health-functional foods with various effects using potential next-generation probiotics such as Akkermansia muciniphila and Faecalibacterium prausnitzii. Those bacterial species among human intestinal microorganisms that have been shown to have a causal relationship with incurable diseases through research in domestic and international. We have completed the construction of the world's largest library and selection of excellent seed strains, and we have the original technology for mass production and commercialization and have acquired a patent. Human application testing for Akkermansia Muciniphila's respiratory health (ETB-F01) has been completed, and human application testing for reduction of body fat, improvement of sensitive skin, and hair loss is currently in progress. Additionally, we are preparing for phase 1 clinical trials to develop microbiome-based medicines. Enterobiome Inc. stepped forward to enter the market and we are in the process of obtaining Akkermansia muciniphila US certification NDA, GRAS, and Korean certification. At the moment we are delighted to open a Licensing-out business including technical transfer and co-development partnership. Distributors are also welcome and we will have a good opportunity to start and set up a new business with Akkermansia muciniphila which is next-generation probiotics.

(주)엔테로바이옴(Enterobiome inc.) revenue & valuation

Annual revenue	$941,105
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$3,100,000
Total funding	No funding

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

C-Suite

Director

Employees by Department

(주)엔테로바이옴(Enterobiome inc.) has 3 employees across 2 departments.

Departments

Number of employees

Funding Data

(주)엔테로바이옴(Enterobiome inc.) has never raised funding before.

(주)엔테로바이옴(Enterobiome inc.) Tech Stack

Discover the technologies and tools that power (주)엔테로바이옴(Enterobiome inc.)'s digital infrastructure, from frameworks to analytics platforms.

Sectigo

SSL/TLS certificate authorities

Nginx

Reverse proxies

Frequently asked questions

(주)엔테로바이옴(Enterobiome inc.) is located in Goyang-si, KR.

You can reach (주)엔테로바이옴(Enterobiome inc.) at +82319687456.

(주)엔테로바이옴(Enterobiome inc.) was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.

(주)엔테로바이옴(Enterobiome inc.) has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.